10835 Road to the Cure
San Diego , CA 92121

Executive/
Director

Price

  • Last Close
  • $ 3.02
    $ +0.13 4.32 %
    Dec 6, 2024
  • 52-Week High/Low
  • $3.15 - $1.67
  • YTD
  • 41.8%

  • Trading Volume
  • 30,437
  • Market Cap Full
  • $ 456.3M
  • Shares Outstanding
  • 151.1M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -44.3% -30.2% -3.3%
Q2 - - - - - - - -35.2% -8.3% -0.5%
Q3 - - - - - - 14.9% 40% -28.6% -
Q4 - - - - - - -22.9% -44.7% 10.4% -
J F M A M J J A S O N D
2024 -21.6% 42.5% -13.5% 4.4% - - - - - - - -
2023 -7.2% -10% -16.4% -8.3% -1.8% 1.9% -4.4% -1.9% -23.9% 17.3% -26.4% 25.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-72%-51%42%

Earnings

2021 2022 2023
Q1 -0.81 -0.31 -0.22
Q2 -1.2 -0.3 -0.21
Q3 -0.46 -0.29 -0.20
Q4 0.62 -1.09 -
A -1.9 -2 -0.63

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 121.6 150.6
Jun - 121.9 150.8
Sep 121.2 122.1 151
Dec 121.3 122.4 151.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Total Asset Turnover - - - - -
Fixed Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 61.8 62.5 15.6 - -
Equity multiplier 0.1 0.1 - - -